Caplight Directory>Companies>Cellevolve Bio-preview>Cellevolve-bio


Cellevolve Bio

Cellevolve Bio

Private
San Francisco, CaliforniaHealthcare & Life Scienceshttp://www.cellevolve.com

Last Round

Seed

Nov 18, 2021

Total Funding Raised

$6M

Company Overview

Cellevolve Bio is a drug discovery company that operates as a development and commercialization company intended to focus on cell therapies for neglected diseases.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Clinical Trials, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting, Revenue Share

AI Layer

Non-AI

Keywords

cell therapyallogeneic T-cell therapyoff-the-shelf cell therapyProgressive Multifocal LeukoencephalopathyPMLT-cell therapyrare diseasesdrug commercializationclinical-stage biotechcell therapy developmentJC viruscell therapy manufacturingdrug in-licensing

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Cellevolve Bio Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Cellevolve Bio Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
SeedNov 18, 2021
View all Funding Rounds

Cellevolve Bio Investors

Notable investors and investment history

InvestorRounds
Hibiscus BioVenturesSeed
Jumpstart NovaSeed
View all Investors

Cellevolve Bio Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Cellevolve Bio Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Cellevolve Bio's valuation, stock price, and market status.

Firmographic Details

HeadquartersSan Francisco, California
Employee Range1
Year Founded2020
Last FundingNov 18, 2021

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.





Caplight Logo




Use CasesInvestorsEmployees

CompaniesAll Companies

LegalPrivacy PolicyTerms of UseBrokerCheckForm CRS


Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.